Indegene Limited

NSE INDGN.NS

Indegene Limited Return on Capital Employed (ROCE) for the year ending March 31, 2024: 22.47%

Indegene Limited Return on Capital Employed (ROCE) is 22.47% for the year ending March 31, 2024, a -2.31% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Indegene Limited Return on Capital Employed (ROCE) for the year ending March 31, 2023 was 23.00%, a -9.66% change year over year.
  • Indegene Limited Return on Capital Employed (ROCE) for the year ending March 31, 2022 was 25.46%, a -55.27% change year over year.
  • Indegene Limited Return on Capital Employed (ROCE) for the year ending March 31, 2021 was 56.92%, a 61.04% change year over year.
  • Indegene Limited Return on Capital Employed (ROCE) for the year ending March 31, 2020 was 35.34%.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
SV Wall Street
NSE: INDGN.NS

Indegene Limited

CEO Mr. Manish Gupta
IPO Date May 13, 2024
Location India
Headquarters Manyata Embassy Business Park
Employees 4,367
Sector Healthcare
Industries
Biotechnology 3D Printing Clinical Trials Hardware & Electronics Medical Instruments Pharmaceuticals Telehealth
Description

Indegene Limited operates as a life sciences commercialization company in India and internationally. It helps biopharmaceutical, emerging biotech, and medical device companies develop products, get to the market, and grow impact through the life cycle. The company offers enterprise commercial solutions, enterprise medical solutions, enterprise clinical solutions, omnichannel activation solutions, and NEXT technology platforms. The company was incorporated in 1998 and is based in Bengaluru, India.

StockViz Staff

February 12, 2025

Any question? Send us an email